Major in Biological Technology

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder

PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL ), today announced that it has begun to market and distribute EMSAM(R) in the U.S. EMSAM, a selegiline transdermal system, is a monoamine oxidase inhibitor (MAOI), which was approved by the U.S. Food a...

DuPont Innovation Addressing Major Global Market Trends

CEO Ellen Kullman Updates Investors on Growth Opportunities in Increasing Food Productivity, Decreasing Dependence on Fossil Fuels, Protecting Lives, Growing in Emerging Markets NEW YORK, May 28 /PRNewswire-FirstCall/ -- DuPont (NYSE: DD ) is well-positioned for growth opportunities with in...

Canadian research team reports major breakthrough in lithium battery technology

This release is available in French . An NSERC-funded lab at the University Of Waterloo has laid the groundwork for a lithium battery that can store and deliver more than three times the power of conventional lithium ion batteries. The research team of professor Linda Nazar, graduate stu...

Four Major Universities Join Nation's Leading Postgrad Bio Jobs Board

SANTA CRUZ, Calif., May 12 /PRNewswire/ -- Four prestigious universities have joined Bio Career Center, the nation's leading online jobs board and careers site for life science professionals. UCLA , Brown , NYU and Georgetown are now members of the jobs board, joining 15 other majo...

NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions

- Up to $50 Million Potential Milestones plus Double Digit Royalties on Future Sales - - Company to Host Conference Call at 11:00 a.m. ET Today - EMERYVILLE, Calif., March 25 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY ), a mid-stage biopharmaceutical comp...

Honeywell Technology Selected to Control Manufacturing Processes at Major U.S. Biotech Site

Solutions Will Help Drive Production Efficiency and Reliability for New Shire Human Genetic Therapies Facility PHOENIX, March 12 /PRNewswire-FirstCall/ -- Honeywell (NYSE: HON ) today announced it will help a leading specialty biopharmaceutical organization expand its research and develop...

State-of-the-art electron microscope promises to aid major research advances

TEMPE, Ariz. Arizona State University will be home to one of the world's most advanced electron microscopes, one that will enable researchers to do work essential to making significant advances in nanoscale aspects of solid state science and materials science and engineering. The National Scie...

Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company

WALTHAM, Mass., March 5 /PRNewswire/ -- Proteon Therapeutics, Inc., announced today that it has successfully completed a $38 million Series B equity financing, led by MPM Capital on behalf of the MPM Bio IV NVS Strategic Fund L.P. This announcement follows the initiation of a Phase 1/2 human clin...

Epistem Announces Research and Development Collaboration With a Major Pharmaceutical Company

MANCHESTER, England, March 2 /PRNewswire-FirstCall/ -- Epistem Plc (LSE:EHP) the UK biotechnology and research services company announced today that they have signed a research and development collaboration with Novartis to identify new drug targets and therapeutics across a variety of disease...

EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone

VIENNA, Austria and CUXHAVEN, Germany, February 26 /PRNewswire/ -- EUCODIS Bioscience, a company developing proteins for the chemical industry, and Lohmann Animal Health (LAH), a company developing and marketing products for animal nutrition and animal health, today announced the achievement o...

Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe

PARIS, January 24 /PRNewswire/ -- The European Commission has granted marketing authorisation for Servier's Valdoxan(R) /Thymanax(R) (agomelatine), the first melatonergic antidepressant for the treatment of adult patients with major depressive episodes. "There is still great scope for i...

Hepatitis C Virus Patient Opportunity Exists Within Many of the Major U.S. Local Markets

However, Insurance Coverage of Hepatitis C Patients Is Skewed Towards Medicare and Medicaid Compared With Dominance of Private Coverage in the General Population, According to a New Analytics Tool From Decision Resources WALTHAM, Mass., Feb. 12 /PRNewswire/ -- Decision Resources, one of the w...

On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability

ANN ARBOR, Mich., Feb. 10 /PRNewswire/ -- Compendia Bioscience, Inc. today announced the results of a third productive year, including a 100 percent renewal rate from its customers. New customers and increased commitments from existing customers, including multi-year agreements from three of the T...

Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company

WAYNE, Pa., Jan. 27 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO ) , a full service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmac...

Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference

FORT LAUDERDALE, Fla., Jan. 27 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS), a pioneer in laser optical breast imaging, will exhibit the CT Laser Mammography (CTLM(R)) system at the Arab Health 2009 medical conference, January 26-29, 2009, in Dubai, Un...

Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting

SAN DIEGO, Nov. 21 /PRNewswire-FirstCall/ -- Gen-Probe's (Nasdaq: GPRO ) CE-marked APTIMA(R) HPV assay may be an important new molecular tool to more accurately detect high-risk human papillomavirus (HPV) infections that are associated with cervical cancer or precancerous lesions, according to n...

Oridion Signs Agreement With Major US Health Plan Provider for Microstream(R) Capnography

JERUSALEM and NEEDHAM, Massachusetts, October 30 /PRNewswire-FirstCall/ -- Oridion Systems Ltd. (SWX: ORIDN) today announced a three-year purchase agreement with Kaiser Foundation Health Plan, Inc., America's largest non-profit health care provider and the largest non-military medical customer...

GlaxoSmithKline and Cellzome Announce Major Strategic Alliance

Kinobeads(TM) Technology to Identify a New Generation of Drug Candidates for Inflammatory Diseases LONDON and CAMBRIDGE, England and PHILADELPHIA and HEIDELBERG, Germany, September 10 /PRNewswire/ -- Cellzome Inc. and GlaxoSmithKline (LSE & NYSE: GSK) announce the signing...

Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances

Security and law enforcement officials may some day have a new ally - a universal detection system that can monitor the air for virtually all of the major threat agents that could be used by terrorists. This type of system is under development by a team of Lawrence Livermore National Laboratory...

Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets

AMSTERDAM, The Netherlands and BARCELONA, Spain, July 15 /PRNewswire-FirstCall/ -- Agendia BV and Ferrer inCode today announced an agreement that will give Ferrer exclusive rights to sell two of Agendia's signature cancer diagnostic services -- MammaPrint(R), a prognostic test that uses a 70-g...

Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities.

Harvard University and Northeastern University Technology Receive Funding From Allied Minds to Commercialize Novel Technology for the Extraction of Aliquots BOSTON, July 2 /PRNewswire/ -- Allied Minds, a pre-seed investment corporation specializing in early stage...

Exiqon: Major Shareholder Announcement

VEDBAEK, Denmark, June 30 /PRNewswire-FirstCall/ -- Exiqon A/S today received information from Danske Bank, that the Danske Bank Group - including Danica Pension Livsforsikring and Danske Fund FCP - through acquisition today of 502,300 shares now owns 1,804,514 shares of a nominal value of eac...

Palladian Muscular Skeletal Health (formerly Prism Health Networks) to Promote Collaborative, Expanded Practice Model at Major Insurance Conference in June

Muscular Skeletal Managed Care Organization Takes Prominent Position and Schedules High-Visibility Activities at AHIP Conference WEST SENECA, N.Y., June 11 /PRNewswire/ -- Palladian Muscular Skeletal Health (formerly Prism Health Networks) today announced their plans to create a high-pr...

Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable

LOS ANGELES, May 27 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationall...

BioElectronics Corporation Receives Major Orders From Italian Distributor

ActiPatch(TM) Chosen as A Safe and Effective Alternative to NSAIDs, Such As Vioxx(R) and Celebrex(R) FREDERICK, Md., May 5 /PRNewswire-FirstCall/ -- BioElectronics Corporation (Pink Sheets: BIEL), the maker of the ActiPatch(TM), a drug free anti-inflammatory patch, with an...

deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer

Markers will form the basis of a DNA diagnostic test to identify women who may benefit from more intensive screening; latest findings folded into deCODEme(TM) REYKJAVIK, Iceland, April 27 /PRNewswire-FirstCall/ -- Scientists from deCODE genetics (Nasdaq: DCGN ) ...

Syngenta To Build Major Global Biotech Research Center in Beijing, China

BASEL, Switzerland, April 17 /PRNewswire-FirstCall/ -- Syngenta today announced that it will build a new biotech research & technology center in Beijing, China. Its focus will be on early-stage evaluation of GM and native traits for key crops such as corn and soy, in the areas of yield improve...

Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing

SALT LAKE CITY, March 17 /PRNewswire/ -- Axial Biotech, Inc., a company revolutionizing spine care through the development of molecular diagnostics and motion preserving technologies, announced today that it has met several major scientific milestones in its development of the first genetic pr...

Cardiac Science Unveils Major Brand Change; Strategy to Lift Brand Awareness

BOTHELL, Wash., March 6 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX ), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it aligned the power of its leading product brands (Burdick(R), HeartCent...

FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder

MADISON, N.J., Feb. 29 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), announced today that the U.S. Food and Drug Administration (FDA) has approved PRISTIQ(TM) (desvenlafaxine), a structurally novel, once-daily serotonin-norepinephrine reuptake inhibitor (S...

AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder

WILMINGTON, Del., Feb. 29 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets to seek approva...

CyberKnife Users' Meeting Highlights Major Clinical Data Milestones and Emerging Trends

Large Scale Study Results Presented in Prostate, Lung and Brain Tumor Treatment SUNNYVALE, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, today announced key clinical presentation hig...

Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents

PROENCY will provide real-world clinical data on the PROMUS(TM) Stent NATICK, Mass., Feb. 11 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that the first patient has been enrolled in its PROENCY (PROMUS(TM), ENdeavor(R) and CYpher(R)) European registry....

Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ' ... Major Weapon in the Battle Against Cancer'

NEWPORT NEWS, Va., Feb 7 /PRNewswire/ -- Dilon Technologies, makers of a gamma imaging system optimized for early breast cancer detection, has appointed Robert G. Moussa to the position of President and Chief Executive Officer. Moussa has a long and successful record in the medical device in...

Vestibular Technologies Is Awarded Contract by Major Group Purchasing Organization (GPO)

CHEYENNE, Wyo., Feb. 4 /PRNewswire/ -- Vestibular Technologies is pleased to announce that it has been awarded a contract in the physical therapy products portfolio with Premier Purchasing Partners, LP, one of the nation's largest and most prestigious group purchasing organizations (GPOs). O...

Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference

CTLM Technology to be Highlighted at Molecular Imaging Conference FORT LAUDERDALE, Fla., Jan. 29 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) a pioneer in laser optical breast imaging, is exhibiting at Arab Health 2008, January 28 - 31, 2008, in Dub...

AMT's Lead Product Poised to Address Major Liver Disease

AMSTERDAM, The Netherlands, January 28 /PRNewswire-FirstCall/ -- - European Patent Office Grants Patent for Treatment of Non-Alcoholic Steatotic Hepatitis AMT (Euronext: AMT), a leader in the field of human gene therapy, today announced that the European Patent Office (EPO) has granted the...

SDCRM Receives Highest Score in Three of Four Categories from CIRM on Part I of Major Facilities Grant Application

SAN DIEGO, Jan. 18 /PRNewswire/ -- The San Diego Consortium for Regenerative Medicine (SDCRM) today announced that it has received the highest score in three of four categories from the California Institute of Regenerative Medicine (CIRM) on Part I of the Major Facilities Grant Application. ...

New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo

Data Presented for the First Time on 50 mg/Day Dose for PRISTIQ for the Treatment of Major Depressive Disorder COLLEGEVILLE, Pa., Dec. 12 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), announces that data from two Phase 3 clinical studies of...

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)

- ABILIFY Used With Another Antidepressant Can Help Adults Living With Depression Who Have Failed to Achieve Adequate Symptom Relief -(1) PRINCETON, N.J. and TOKYO, Nov. 20 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY ) and Otsuka Pharmaceutical Co., Ltd. announced tod...